USP10 and esophageal squamous cell carcinoma: These data indicate that F806 targetes USP10 but does not affect the binding of Cdh1 to ANLN, thus altering the ubiquitination-deubiquitination balance of ANLN and inducing M-phase delay in ESCC cells (Fig. 7J).